Page 5,427«..1020..5,4265,4275,4285,429..5,4405,450..»

New Lawsuit on Granuflo Stroke: Now, AttorneyOne Can Provide Advice

Posted: Published on April 17th, 2013

According to court documents, on January25th, 2013 a man filed a lawsuit in Louisiana Eastern District Court alleging he suffered heart attack and stroke following hemodialysis treatment with Granuflo and/or Naturalyte. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Granuflo side effects. San Diego, CA (PRWEB) April 15, 2013 According to court documents, on January25th, 2013 a man filed a lawsuit in Louisiana Eastern District Court (case no. 2:2013cv00147) alleging he suffered heart attack and stroke as well as severe pain and suffering following hemodialysis treatment with Granuflo and/or Naturalyte. Granuflo, manufactured by Fresenius Medical Care, is an additive used in kidney dialysis to help patients maintain their bicarbonate levels which neutralize the acid buildup in the bloodstream during dialysis. A lawsuit was filed on January 14th, 2013 by a Texas woman in Massachusetts District Court (case no. 1:2013cv10082) alleging her husband felt ill after hemodialysis treatment with Granuflo and two days later died of a heart attack. Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion … Continue reading →

Comments Off on New Lawsuit on Granuflo Stroke: Now, AttorneyOne Can Provide Advice

The National Parkinson Foundation's Medical Director Shares the 10 Secrets to a Happier Life with Parkinson's Disease

Posted: Published on April 17th, 2013

--New Parkinson's Treatment Book Translated into 20+ Languages-- MIAMI, April 17, 2013 /PRNewswire-USNewswire/ -- The National Parkinson Foundation's (NPF) medical director, Michael S. Okun, M.D., has released a new book titled, "Parkinson's Treatment: 10 Secrets to a Happier Life." Published this month, in conjunction with Parkinson's Awareness Month, the book is now available in more than twenty languages to help people all over the world live their best life with Parkinson's disease. "Through my interactions with thousands of Parkinson's patients, I have come to realize you do not have to be defined by the disease," said Okun, NPF medical director and co-director of UF Center for Movement Disorders and Neurorestoration, an NPF Center of Excellence. "The purpose of this book is to provide a roadmap to health, hope and happiness for a full and meaningful life with Parkinson's." Based on Okun's experience as a movement disorders specialist, the book addresses the issues surrounding Parkinson's disease and the secrets that have helped people live well and live longer. The comprehensive book includes chapters on issues such as medication timing, deep brain stimulation surgery, depression, sleep and exercise. "Dr. Okun's book is a must-read for anyone who has recently been diagnosed with … Continue reading →

Posted in Parkinson's Treatment | Comments Off on The National Parkinson Foundation's Medical Director Shares the 10 Secrets to a Happier Life with Parkinson's Disease

Forrest Gregg fighting Parkinson's, not the NFL

Posted: Published on April 17th, 2013

GREENWOOD VILLAGE, Colo. (AP) Hall of Famer Forrest Gregg says that while he and his neurologist blame concussions for his Parkinson's disease, he's not going to sue the NFL like thousands of other former players. The 79-year-old says he doesn't begrudge those who have joined the lawsuits but he has his pensions from his playing and coaching days and "I don't need anything from anybody but what I earned." He said he's an "independent type" and doesn't believe in holding others accountable for his well-being. "And my experience in the National Football League was good," said Gregg, who is promoting UCB, Inc.'s "Parkinson's More Than Motion" campaign during Parkinson's Awareness Month. Gregg said he's doing well 18 months after his diagnosis and credits medicine, exercise and daily phone calls from his son and former teammates to reminisce about the good ol' days, which keeps his mind sharp. The former offensive lineman known as "Iron Man" said he wants to help others recognize the signs of Parkinson's and seek treatment early enough to delay the degenerative effects of the chronic, debilitating disease on both mind and body. When Gregg was diagnosed, his neurologist, Dr. Rajeev Kumar, a Parkinson's expert and medical … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Forrest Gregg fighting Parkinson's, not the NFL

Study Points To Treatment For Cerebral Palsy

Posted: Published on April 17th, 2013

A new technique being heralded as a breakthrough could have significant implications for the treatment of cerebral palsy. Researchers say theyve found a way to transform ordinary skin cells into brain cells that are missing or damaged in individuals with cerebral palsy and related disorders like multiple sclerosis. In such conditions, so-called myelinating cells which help the brain send instructions to the rest of the body cannot naturally be replaced. In a study published Sunday in the journal Nature Biotechnology, scientists say they have successfully used the technique to alter cells from mice and are now looking to test it on human cells. The approach dubbed cellular reprogramming is particularly promising, researchers say, because it relies on fibroblasts, a type of cell found in skin and many organs, that is abundantly available. We are taking a readily accessible and abundant cell and completely switching its identity to become a highly valuable cell for therapy, said Paul Tesar, assistant professor of genetics and genome sciences at Case Western Reserve School of Medicine and a senior author of the study. Read the original here: Study Points To Treatment For Cerebral Palsy … Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on Study Points To Treatment For Cerebral Palsy

Acorda's MS drug proves to help stroke patients walk again, study finds

Posted: Published on April 17th, 2013

A phase II study proved a drug that helps multiple sclerosis patients walk can also help stroke patients walk, Medical News Today reported. Acorda Therapeutics, which makes Ampyra (dalfampridine), said patients with post-stroke deficits such as impaired walking, motor and/or sensory function and manual dexterity showed significant improvement after taking the extended release tablets. There were clear efficacy signals in the dalfampridine-ER post-stroke deficits trial, and we therefore plan to proceed with a clinical development program for this indication, said Dr. Ron Cohen, president and CEO of Acorda. A top-line analysis of the data found dalfampridine-ER improved walking for people with mobility impairment resulting from ischemic stroke. Dalfampridine-ER treatment was also associated with a positive change versus placebo on a scale of functional independence in this study. Cohen said after the company analyzes more data, it will be in touch with the Food and Drug Administration so a much larger study can be conducted. Cohen said there are more than 7 million stroke survivors in the United States, and about half of them have lasting mobility impairment, which does not benefit from any available medications. Because of this, he said the drug is desperately needed. The phase II trial involved … Continue reading →

Posted in MS Treatment | Comments Off on Acorda's MS drug proves to help stroke patients walk again, study finds

Robin Bernhoft, M.D. – Bio-Identical Hormone Replacement, Los Angeles with Randy Alvarez – Video

Posted: Published on April 17th, 2013

Robin Bernhoft, M.D. - Bio-Identical Hormone Replacement, Los Angeles with Randy Alvarez Randy Alvarez, host of The Wellness Hour, discussing Bio-Identical Hormone Replacement Therapy with Dr. Robin Bernhoft. By: thewellnesshour … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Robin Bernhoft, M.D. – Bio-Identical Hormone Replacement, Los Angeles with Randy Alvarez – Video

Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged Adult Stem Cells Can Be Functionally Reprogrammed To Act …

Posted: Published on April 17th, 2013

MONTCLAIR, N.J., April 16, 2013 /PRNewswire/ --A preliminary research study, which found that adult stem cells may be functionally reprogrammed to act like younger cells, was presented by Dr. Vincent Giampapa at The Second International Vatican Stem Cell Conference: Regenerative Medicine A Fundamental Shift in Science and Culture, from within the Vatican, held between April 11-13, 2013. The research, which has potential implications in the restoration of human immune function, was conducted by researchers affiliated with CellHealth Institute. (Logo:http://photos.prnewswire.com/prnh/20130327/LA84207LOGO) Dr. Vincent Giampapa, chief medical officer of CellHealth Institute, faculty at UMDNJ's Medical School, and principal investigator of the research, revealed that the preliminary findings support further research into the reprogramming of adult stem cells. This research could lead to a major breakthrough in treating chronic illnesses, enhancing immune response and the maintenance of optimal health. "Although this is a pilot study, this is the first time that adult stem cells have been functionally reprogrammed to act as younger versions of themselves," said Dr. Giampapa. "The implications for future use in the restoration of immune function as well as the cell regeneration in aging humans is plausible. It's early days, but the signs are there to give us great hope as … Continue reading →

Posted in Stem Cell Research | Comments Off on Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged Adult Stem Cells Can Be Functionally Reprogrammed To Act …

FDA Approves Phase II of Stem Cell Trial for ALS

Posted: Published on April 17th, 2013

Newswise ANN ARBOR, Mich. For nearly two years, University of Michigan neurologist Eva Feldman, M.D., Ph.D. has led the nations first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrigs disease. Now, a new approval from the U.S. Food and Drug Administration paves the way for U-M to become the second site in the trial, pending approval of the U-M Institutional Review Board. To date, the first phase of the trial has taken place at Emory University, with Feldman serving as principal investigator. The FDA approval of a Phase II trial was announced today by Neuralstem, the company whose product the trial is testing. The Phase II trial will continue to evaluate the safety of the stem cell injections, delivered directly into patients spinal cords in escalating doses of up to 400,000 cells per injection, with a maximum of 40 injections. It will also assess any signs that the injections might be impacting patients ALS symptoms or progression. Feldman serves as an unpaid consultant to the company, and has led the analysis of results from the Phase I trial. In data presented last year, spinal … Continue reading →

Posted in Stem Cell Research | Comments Off on FDA Approves Phase II of Stem Cell Trial for ALS

San Diego, CA to Host World Stem Cell Summit December 4-6, 2013

Posted: Published on April 17th, 2013

SAN DIEGO--(BUSINESS WIRE)-- Genetics Policy Institute (GPI) announced today that the 9th annual World Stem Cell Summit is scheduled for December 4-6, 2013, at the Hilton Bayfront San Diego. Genetics Policy Institute (GPI), California Institute for Regenerative Medicine (CIRM), Mayo Clinic, The Scripps Research Institute (TSRI) and Sanford-Burnham Medical Research Institute (Sanford-Burnham) have joined to organize the largest and most comprehensive multi-track interdisciplinary stem cell conference aimed at uniting the global stem cell community and accelerating cures. Additional international organizers will be named in the coming weeks. Bernard Siegel (GPI), Dr. Jeanne Loring (TSRI), Dr. Andre Terzic (Mayo Clinic), Dr. Evan Snyder (Sanford-Burnham) and Dr. Alan Trounson (CIRM) will serve as co-chairs of the Summit. The Summit features pre-eminent researchers, industry leaders, clinicians, hospital administrators, regulators, advocates, philanthropists, economic development officers, media representatives and experts in law and insurance. More than 170 experts will discuss the latest scientific discoveries, business models, translational issues, legal and regulatory solutions and best practices. The event is expected to attract more than 1,200 attendees from 40 nations, and 200 sponsors, media partners and endorsing organizations. The Summit provides an exhibition hall, country pavilions, specialized symposiums, networking receptions, the GPI Stem Cell Action Awards Dinner … Continue reading →

Posted in Stem Cell Research | Comments Off on San Diego, CA to Host World Stem Cell Summit December 4-6, 2013

BGI Health forms partnership with ACIBADEM hospital on genetic disease testing

Posted: Published on April 17th, 2013

Public release date: 15-Apr-2013 [ | E-mail | Share ] Contact: Jia Liu liujia@genomics.cn BGI Shenzhen Shenzhen, China, April 16, 2013 - BGI Health and ACIBADEM Healthcare Group Genetic Diagnostic Center in cooperation with Genoks Company Molecular Biology, signed a Memorandum of Understanding (MoU) for jointly introducing the advanced genetic testing technologies to Turkey and improving Turkish reproductive healthcare. This partnership will foster the applications of genetic testing technologies in the areas of Monogenic disorders, personalized medical healthcare, birth defects that cause terrible diseases, among others. With the fast development of scientific technologies, there are a variety of testing tools that parents can use to look into their baby's future health, or to predict some of most serious hereditary diseases. Among them, genetic testing is the latest and most sophisticated of techniques used to detect gene variants associated with a specific disease or condition. In the clinical applications, genetic testing technologies can be performed to confirm a suspected diagnosis, to predict the possibility of future illness, to detect the presence of a carrier state in unaffected individuals (whose children may be at risk), and to predict response to therapy. Considering the potential and importance of genetic testing, ACIBADEM Healthcare Group … Continue reading →

Comments Off on BGI Health forms partnership with ACIBADEM hospital on genetic disease testing

Page 5,427«..1020..5,4265,4275,4285,429..5,4405,450..»